https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-023-16265-8
0
0
A prospective cohort study protocol: monitoring and surveillance of adverse events following heterologous booster doses of Oxford AstraZeneca COVID-19 vaccine in previous recipients of two doses of Sinopharm or Sputnik V vaccines in Iran - BMC Public He - BMC Public Health
+ 113 more
7/24/23 at 10:49am
Organization
Biomedcentral.com
84 words
0
Comments
Background Regarding the paucity of evidence on the side effects of the booster dose of Oxford AstraZeneca vaccine in vaccinated people with Sinopharm or Sputnik V, we aimed to set up a cohort event monitoring (CEM) study to capture adverse events occurring i…
You are the first to view
Create an account or login to join the discussion